| 英文名称 | 中文名称 | CAS | MF |
|
4-{[(E)-2-naphthylmethylidene]amino}benzamide
|
|
|
C18H14N2O
|
|
(E)-3-(1-naphthyl)-N'-(2-phenylacetyl)-2-propenohydrazide
|
|
|
C21H18N2O2
|
|
2-{[(E)-2-naphthylmethylidene]amino}benzamide
|
|
|
C18H14N2O
|
|
(E)-3-(1-naphthyl)-N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-propenamide
|
|
|
C23H22N2O3S
|
|
3-{[(E)-2-naphthylmethylidene]amino}benzonitrile
|
|
|
C18H12N2
|
|
(E)-3-(1-naphthyl)-N-phenyl-2-propenamide
|
|
|
C19H15NO
|
|
4-{[(E)-1-naphthylmethylidene]amino}phenol
|
|
|
C17H13NO
|
|
(E)-3-(1-naphthyl)-N-(2'-{[(E)-3-(1-naphthyl)-2-propenoyl]amino}[1,1'-biphenyl]-2-yl)-2-propenamide
|
|
|
C38H28N2O2
|
|
(E)-3-(1-naphthyl)-N'-(4-{2-[(E)-3-(1-naphthyl)-2-propenoyl]hydrazino}-4-oxobutanoyl)-2-propenohydrazide
|
|
|
C30H26N4O4
|
|
(E)-3-(1-naphthyl)-N-(2-{[(E)-3-(1-naphthyl)-2-propenoyl]amino}phenyl)-2-propenamide
|
|
|
C32H24N2O2
|
|
2-{[(E)-1-naphthylmethylidene]amino}benzamide
|
|
|
C18H14N2O
|
|
(E)-3-(1-naphthyl)-N-(1,3-thiazol-2-yl)-2-propenamide
|
|
|
C16H12N2OS
|
|
(E)-3-(1-naphthyl)-N-{4-[(propylamino)sulfonyl]phenyl}-2-propenamide
|
|
|
C22H22N2O3S
|
|
(E)-3-(1-naphthyl)-N-[2-(1-pyrrolidinylcarbonyl)phenyl]-2-propenamide
|
|
|
C24H22N2O2
|
|
Emko vaginal foam
|
|
|
|
|
ENA Profile ELISA
|
ENA-PROFILE抗体
|
|
|
|
ENA1 protein
|
|
|
|
|
EMK1 protein
|
|
|
|
|
ena protein
|
|
|
|
|
EnaprilMaleate
|
|
|
|
|
ENARGITE
|
|
|
|
|
(E)-N-{[2-([1,1'-biphenyl]-4-ylcarbonyl)hydrazino]carbothioyl}-3-(4-fluorophenyl)-2-propenamide
|
|
|
C23H18FN3O2S
|
|
Enathic anhydride(heptanoic anhydride)
|
|
|
|
|
Eluthiacet E.C.
|
嗪草酸乳油
|
|
|
|
(E)-N,2-BIS(4-METHYLPHENYL)-1-ETHENESULFONAMIDE
|
|
339105-29-2
|
C16H17NO2S
|
|
(E)-N'-(4-(BIS(2-CHLOROETHYL)AMINO)BENZYLIDENE)-2-(5-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)THIAZOLE-4-CARBOHYDRAZIDE
|
|
|
C25H21Cl2F3N6OS
|
|
ELUTION BUFFER
|
|
|
|
|
(E)-3,N-BIS-(4-METHOXY-PHENYL)-ACRYLAMIDE
|
|
|
C17H17NO3
|
|
ElutionMicrotubesCl(24X96)
|
|
|
|
|
ElutionMicrotubesCl(1X96)
|
|
|
|
|
ELVIS
|
|
142525-11-9
|
|
|
Elvitegravir-d6 (Major)
|
五氘代埃替拉韦
|
1131640-69-1
|
C23H23ClFNO5
|
|
EMM AGAR
|
|
|
|
|
EMM AGAR PLUS 1 X SP SUPPLEMENTS-LEU-URA
|
|
|
|
|
ENCAINIDE HYDROCHLORIDE
|
恩卡尼盐酸盐
|
66794-74-9
|
C22H28N2O2.ClH
|
|
Encainide
|
恩卡尼
|
37612-13-8
|
C22H28N2O2
|
|
ENCAPSULATED SAPP 15
|
|
|
|
|
ENCAPSULATED SODIUM ASCORBATE
|
|
|
|
|
ENCAP BUTTER
|
|
|
|
|
ENCAPSULATED VINEGAR POWDER AC-165X-60
|
|
|
|
|
ENCAPSULATED SODIUM ASCOBATE
|
|
|
|
|
encapsulation-relating protein 86
|
|
|
|
|
(E)-N-carbamoyl-2-ethyl-but-2-enamide
|
|
2884-67-5
|
C7H12N2O2
|
|
Encecalin
|
英西卡林
|
20628-09-5
|
C14H16O3
|
|
enbocin
|
|
|
|
|
encecanescin
|
|
87592-85-6
|
C28H34O5
|
|
Enazadrem
|
依那扎群
|
107361-33-1
|
C18H25N3O
|
|
Encelin
|
|
15569-50-3
|
C15H16O3
|
|
ELVNVTENFNMWK
|
|
|
C73H110N18O22S
|
|
Emmenagogue
|
|
|
|
|
Emmenagogue,Cholagogue
|
|
|
|
|
Emmenagogue,Galactagogue
|
|
|
|
|
Emmenagogue,Abortifacient
|
|
|
|
|
EMMENTHAL FLAVOUR CF146.012
|
|
|
|
|
EMMENTAL FLAVOUR
|
|
|
|
|
EMMENTHAL FLAVOUR
|
|
|
|
|
EMMENTAL FLAVOUR, CF146.012
|
|
|
|
|
EMMENTHAL FLAVOUR (CF 146.003)
|
|
|
|
|
EMMENTAL CHEESE FLAVOUR, CF 146.011
|
|
|
|
|
EMMENTAL CHEESE FLAVOUR CF146.004
|
|
|
|
|
EMMENTHAL CHEESE FLAVOUR
|
|
|
|
|
EMMENTHAL CHEESE FLAVOUR (CF146.004)
|
|
|
|
|
EMMENTALERCHEESE
|
|
|
|
|
(E)-N-[4-(1-azepanylsulfonyl)phenyl]-3-(1-naphthyl)-2-propenamide
|
|
|
C25H26N2O3S
|
|
(E)-N-[4-(1-azepanylsulfonyl)phenyl]-3-phenyl-2-propenamide
|
|
|
C21H24N2O3S
|
|
(E)-N-[4-(1-azepanylsulfonyl)phenyl]-3-(2-furyl)-2-propenamide
|
|
|
C19H22N2O4S
|
|
(E)-N-[4-(1-azepanylsulfonyl)phenyl]-3-(2-thienyl)-2-propenamide
|
|
|
C19H22N2O3S2
|
|
(E)-N-[2-(1-azepanylcarbonyl)phenyl]-3-phenyl-2-propenamide
|
|
|
C22H24N2O2
|
|
(E)-N-[4-(1-azepanylsulfonyl)phenyl]-3-(4-methoxyphenyl)-2-propenamide
|
|
|
C22H26N2O4S
|
|
(E)-N-[2-(1-azepanylcarbonyl)phenyl]-3-(2-methoxyphenyl)-2-propenamide
|
|
|
C23H26N2O3
|
|
Encephalitis NS3
|
|
|
|
|
(±)-Elwesine
|
|
|
|
|
ENBP1 protein
|
|
|
|
|
EMLP protocol
|
|
|
|
|
EMMI
|
亚胺乙汞
|
2597-93-5
|
C11H7Cl6HgNO2
|
|
(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinazolin-6-yl)-4-(dimethylamino)-2-fluorobut-2-enamide
|
|
|
C22H22ClF2N5O2
|
|
(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinazolin-6-yl)-2-fluoro-4-(4-methylpiperazin-1-yl)but-2-enamide
|
|
|
C25H27ClF2N6O2
|
|
(E)-N-(4-(3-chloro-4-fluorophenylamino)-7-ethoxyquinazolin-6-yl)-4-((2-(dimethylamino)ethyl)(methyl)amino)-2-fluorobut-2-enamide
|
|
|
C25H29ClF2N6O2
|
|
(E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
|
|
876310-02-0
|
C30H29ClN6O3
|
|
Dacomitinib (PF299804)
|
达克替尼
|
1110813-31-4
|
C24H25ClFN5O2
|
|
(E)-N-(3-chloro-4-Morpholinophenyl)-N'-hydroxyforMiMidaMide
|
N-(3-氯-4-吗啉代苯基)-N'-羟基甲脒
|
339071-18-0
|
C11H14ClN3O2
|
|
(E)-N'-(6-chloropyridazin-3-yl)-N,N-diMethylacetaMidine
|
N-(6-氯吡嗪-3-基)-N,N-二甲基盐酸乙脒
|
68675-27-4
|
C8H11ClN4
|
|
(E)-N-(4-CHLOROBENZYL)-3-(4-[(3-CHLOROBENZYL)OXY]PHENYL)-2-PROPENAMIDE
|
|
477871-18-4
|
C23H19Cl2NO2
|
|
(E)-N-((2-(5-CHLORO-1H-INDOL-3-YL)ETHYLAMINO)(4,6-DIMETHYLPYRIMIDIN-2-YLAMINO)METHYLENE)BENZAMIDE
|
|
|
C24H23ClN6O
|
|
(2E)-N-(4-CHLOROPHENYL)-2-CYANO-2-(HYDROXYIMINO)ACETAMIDE
|
|
|
C9H6ClN3O2
|
|
(E)-N'-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-N'-METHYL-2-PHENYL-3-(2-THIENYL)-2-PROPENOHYDRAZIDE
|
|
478078-55-6
|
C20H15ClF3N3OS
|
|
(E)-N-(2-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]amino}ethyl)-2-(2-methoxyphenyl)-1-ethenesulfonamide
|
|
|
C17H17ClF3N3O3S
|
|
(E)-N-((2-(5-CHLORO-1H-INDOL-3-YL)ETHYLAMINO)(4,6-DIMETHYLPYRIMIDIN-2-YLAMINO)METHYLENE)BIPHENYL-4-CARBOXAMIDE
|
|
|
C30H27ClN6O
|
|
(E)-N'-(4-CHLOROBENZYLIDENE)-2-(5-(NAPHTHALEN-2-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL)THIAZOLE-4-CARBOHYDRAZIDE
|
|
|
C25H15ClF3N5OS
|
|
(E)-N-((2-(5-CHLORO-1H-INDOL-3-YL)ETHYLAMINO)(4,6-DIMETHYLPYRIMIDIN-2-YLAMINO)METHYLENE)-2-(4,6-DIMETHYLPYRIMIDIN-2-YLTHIO)ACETAMIDE
|
|
|
C25H27ClN8OS
|
|
(E)-N-(2-{[3-chloro-5-(trifluoromethyl)-2-pyridinyl]amino}ethyl)-2-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-pyrrol-2-yl}-1-ethenesulfonamide
|
|
|
C20H15Cl2F6N5O2S
|
|
(E)-N-(3-chloro-2-methylphenyl)-3-(3,4-dimethoxyphenyl)-2-propenamide
|
|
|
C18H18ClNO3
|
|
(E)-N-(4-chlorophenyl)-3-(1-naphthyl)-2-propenamide
|
|
|
C19H14ClNO
|
|
(E)-N-(4-chloro-3-nitrophenyl)-3-(4-fluorophenyl)-2-propenamide
|
|
|
C15H10ClFN2O3
|
|
(E)-N-({2-[2-(4-chloro-2-methylphenoxy)acetyl]hydrazino}carbothioyl)-3-(2-furyl)-2-propenamide
|
|
|
C17H16ClN3O4S
|
|
(E)-N-({2-[4-(2-chloroanilino)-4-oxobutanoyl]hydrazino}carbothioyl)-3-(4-fluorophenyl)-2-propenamide
|
|
|
C20H18ClFN4O3S
|
|
(E)-N-(4-chloro-3-nitrophenyl)-3-(3,4-dimethoxyphenyl)-2-propenamide
|
|
|
C17H15ClN2O5
|
|
(E)-N-(4-chlorophenyl)-3-(2-furyl)-2-propenamide
|
|
|
C13H10ClNO2
|
|
(E)-N-({2-[2-(4-chloro-3-methylphenoxy)acetyl]hydrazino}carbothioyl)-3-(2-methoxyphenyl)-2-propenamide
|
|
|
C20H20ClN3O4S
|
|
(E)-N-(4-chloro-3-nitrophenyl)-3-phenyl-2-propenamide
|
|
|
C15H11ClN2O3
|